NMRA
Neumora Therapeutics, Inc. Common Stock
NASDAQ · Healthcare · Biotechnology · US
$1.31
−2.96%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-477.9%
Return on equity
-169.9%
Return on assets
-470.9%
Return on invested capital
0.00x
Asset turnover
-$180.5M
Cash from operations
$0.62
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026